BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 15719386)

  • 1. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.
    Ruf AE; Kremers WK; Chavez LL; Descalzi VI; Podesta LG; Villamil FG
    Liver Transpl; 2005 Mar; 11(3):336-43. PubMed ID: 15719386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sodium predicts mortality in patients listed for liver transplantation.
    Biggins SW; Rodriguez HJ; Bacchetti P; Bass NM; Roberts JP; Terrault NA
    Hepatology; 2005 Jan; 41(1):32-9. PubMed ID: 15690479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based incorporation of serum sodium concentration into MELD.
    Biggins SW; Kim WR; Terrault NA; Saab S; Balan V; Schiano T; Benson J; Therneau T; Kremers W; Wiesner R; Kamath P; Klintmalm G
    Gastroenterology; 2006 May; 130(6):1652-60. PubMed ID: 16697729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis.
    Mathur S; Gane EJ; McCall JL; Plank LD
    J Gastroenterol Hepatol; 2008 Feb; 23(2):239-43. PubMed ID: 17489965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantation.
    Moini M; Hoseini-Asl MK; Taghavi SA; Sagheb MM; Nikeghbalian S; Salahi H; Bahador A; Motazedian M; Jafari P; Malek-Hosseini SA
    Clin Transplant; 2011; 25(4):638-45. PubMed ID: 21077951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
    Luca A; Angermayr B; Bertolini G; Koenig F; Vizzini G; Ploner M; Peck-Radosavljevic M; Gridelli B; Bosch J
    Liver Transpl; 2007 Aug; 13(8):1174-80. PubMed ID: 17663415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
    Gheorghe L; Popescu I; Iacob R; Iacob S; Gheorghe C
    Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of preoperative serum sodium concentration in living donor liver transplantation.
    Fukuhara T; Ikegami T; Morita K; Umeda K; Ueda S; Nagata S; Sugimachi K; Gion T; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y
    J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation.
    Degré D; Bourgeois N; Boon N; Le Moine O; Louis H; Donckier V; El Nakadi I; Closset J; Lingier P; Vereerstraeten P; Gelin M; Adler M
    Transpl Int; 2004 Jan; 17(1):31-8. PubMed ID: 14745489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does model for end-stage liver disease (MELD) require modification?
    Desai HG
    J Assoc Physicians India; 2011 Jun; 59():372-3. PubMed ID: 21751591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.